Latest Breaking News On - Professor andrew wei - Page 1 : comparemela.com

MELBOURNE, Australia  Acute myeloid leukemia (AML) is a particularly aggressive and fast-spreading form of leukemia. It starts in the bone marrow but moves quickly to the blood stream where it can spread to other areas like the lymph nodes, liver, and central nervous system. Physicians consider AML one of the hardest forms of leukemia to treat, but the results of a recent clinical trial indicate a new drug may change all that. Researchers from Monash University say global trials of the drug CC-486 reveals a 30-percent improvement in survival rates among patients. Notably, the drug seems to be especially helpful for AML patients over the age of 55. Considering that the disease usually grows worse as a patient ages, and most older AML patients pass away within two years of diagnosis, finding a treatment is of the utmost importance.

South australiaUnited statesAndrew weiMonash universityMonash university australian centre for blood diseasesDrug administrationAlfred healthProfessor andrew weiMonash university australian centreBlood diseasesதெற்கு ஆஸ்திரேலியாஒன்றுபட்டது மாநிலங்களில்ஆண்ட்ரூ வெய்மோனாஷ் பல்கலைக்கழகம்மோனாஷ் பல்கலைக்கழகம் ஆஸ்திரேலிய மையம் க்கு இரத்தம் நோய்கள்ஆல்ஃபிரட் ஆரோக்கியம்